Follikuláris limfóma: vizsgálatok itt: Izland

1 trial · From EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.

• 2. fázisTaking people
  Primary treatment of follicular lymphoma with rituximab-lenalidomide-tafasitamab for high-risk disease and rituximab-lenalidomide with a 1:1 randomization to tafasitamab for low-risk disease: a phase II study – NLG-FL7

  Where

  Reykjavik

  Életkor

  18 év and over

  People

  270 worldwide

  Run by

  Karolinska University Hospital

  See details and how to join2023-508196-36-00 · EU 2023-508196-36-00